Andrea Park / FierceBiotech:
PathAI, which develops AI-powered technology for disease diagnosis and treatment, raises $165M Series C led by D1 Capital Partners and Kaiser Permanente — If its hundreds of millions in venture funding and wide-ranging cadre of big-named partners are any indication, PathAI’s (ahem) path forward appears to be paved in gold.
Home / Tech / PathAI, which develops AI-powered technology for disease diagnosis and treatment, raises $165M Series C led by D1 Capital Partners and Kaiser Permanente (Andrea Park/FierceBiotech)
Tags 165M AIpowered Andrea Capital Develops diagnosis Disease Kaiser led ParkFierceBiotech partners PathAI Permanente raises Series Technology treatment
Check Also
Intel announces launch of ‘independent trust authority’
Continuing with its slew of launches and announcements as part of the two-day Intel Vision …
Asian Tribune Your Multilingual Newspaper covering World and local news News
